AI Analysis
AI-generated analysis. Always verify with the original filing.
Galera Therapeutics, Inc. announced its Combined 2025 and 2026 Annual Meeting of Stockholders is scheduled for May 8, 2026, and established April 13, 2026 as the deadline for stockholder proposals, nominations, and universal proxy notices.
Key Takeaways
1Annual Meeting date set for May 8, 2026 — establishes timeline for governance actions and proxy process.
2April 13, 2026 is the hard deadline for stockholder notices under Bylaws — late submissions will be invalid.
3Universal proxy notice (Rule 14a-19) must be postmarked or electronically transmitted by April 13, 2026 — required for dissident director solicitations.
4Proposals for inclusion in proxy materials under Rule 14a-8 are considered timely if received on or before April 13, 2026 — sets de facto cutoff for proxy statement drafting.